MUSC researchers used machine learning on fMRI scans to predict which smokers would benefit from repetitive transcranial magnetic stimulation (rTMS) for quitting smoking.
Key Details
- 1MUSC study combines machine learning and fMRI to personalize rTMS for smoking cessation.
- 242 participants took part in an earlier study, split into real vs sham TMS groups.
- 3The salience network's connectivity in the brain, analyzed by AI, correlated best with positive rTMS outcomes.
- 4Machine learning enabled predictions of individual responsiveness to rTMS based on brain network analysis.
- 5Study published in Brain Connectivity; NIH grant support cited.
- 6The research establishes groundwork for precision neuromodulation and larger future trials.
Why It Matters
This study demonstrates how imaging AI can enhance precision medicine by analyzing fMRI scans to tailor neuromodulation therapies. The approach could extend to other substance use disorders, highlighting a broader potential impact for radiology-based AI tools.
Source
EurekAlert
Related News
•EurekAlert
AI Accurately Predicts Lymph Node Extension in HPV-related Throat Cancer via CT
An AI pipeline automates lymph node segmentation and extranodal extension prediction from CT in HPV-positive oropharyngeal cancer, correlating with patient outcomes.
•EurekAlert
Study Finds Doctors, Nurses Outperform AI for Emergency Triage
Clinical staff outperform ChatGPT AI at emergency department triage, but AI shows promise as a support tool for urgent cases.
•EurekAlert
AI-Enhanced CT Model Improves HCC Risk Prediction in Cirrhosis
Combining CT-based radiomics and deep learning features with clinical data enhances prediction of hepatocellular carcinoma risk in cirrhosis patients.